Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Wallace Brownlee; Dennis Bourdette; Simon Broadley; Joep Killestein; Olga Ciccarelli

doi:10.1212/WNL.0000000000009507

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Wallace Brownlee, Dennis Bourdette, Simon Broadley, Joep Killestein, Olga Ciccarelli

Neurology

Research output: Contribution to journal › Review article › peer-review

147 Scopus citations

Abstract

The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

Original language	English (US)
Pages (from-to)	949-952
Number of pages	4
Journal	Neurology
Volume	94
Issue number	22
DOIs	https://doi.org/10.1212/WNL.0000000000009507
State	Published - Jun 2 2020

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000009507

Cite this

@article{5a340b0df57c48fda04efbba9cc184bd,

title = "Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic",

abstract = "The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).",

author = "Wallace Brownlee and Dennis Bourdette and Simon Broadley and Joep Killestein and Olga Ciccarelli",

note = "Publisher Copyright: {\textcopyright} American Academy of Neurology.",

year = "2020",

month = jun,

day = "2",

doi = "10.1212/WNL.0000000000009507",

language = "English (US)",

volume = "94",

pages = "949--952",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "22",

}

TY - JOUR

T1 - Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

AU - Brownlee, Wallace

AU - Bourdette, Dennis

AU - Broadley, Simon

AU - Killestein, Joep

AU - Ciccarelli, Olga

N1 - Publisher Copyright: © American Academy of Neurology.

PY - 2020/6/2

Y1 - 2020/6/2

N2 - The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

AB - The emergence of novel coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).

UR - http://www.scopus.com/inward/record.url?scp=85084446157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084446157&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000009507

DO - 10.1212/WNL.0000000000009507

M3 - Review article

C2 - 32241953

AN - SCOPUS:85084446157

SN - 0028-3878

VL - 94

SP - 949

EP - 952

JO - Neurology

JF - Neurology

IS - 22

ER -

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this